Works matching DE "CANCER chemotherapy"


Results: 5000
    1

    Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1585884
    By:
    • Tortorelli, Ilaria;
    • Chiusole, Benedetta;
    • Murtas, Fabio;
    • Galiano, Antonella;
    • Bolshinsky, Maital;
    • Ahcene-Djaballah, Selma;
    • De Toni, Chiara;
    • Vizzaccaro, Salvatore;
    • Maruzzo, Marco;
    • Basso, Umberto;
    • Banzato, Alberto;
    • Coppola, Marina;
    • Lonardi, Sara;
    • Zagonel, Vittorina;
    • Brunello, Antonella
    Publication type:
    Article
    2

    Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study

    Published in:
    Oncology, 2025, v. 103, n. 7, p. 549, doi. 10.1159/000542291
    By:
    • Kuo, Li-Fu;
    • Liu, Wen-Chun;
    • Li, Ming-Feng;
    • Huang, Fu-Huan;
    • Chou, Chu-Kuang;
    • Chen, Tsung-Hsien;
    • Tsai, Yi-Tseng;
    • Hsu, Ping-I.;
    • Li, Chao-Jen;
    • Wu, I.-Ting;
    • Tsai, Kun-Feng
    Publication type:
    Article
    3

    Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.

    Published in:
    Oncology, 2025, v. 103, n. 7, p. 569, doi. 10.1159/000542137
    By:
    • Araki, Tomonori;
    • Kawahira, Machiko;
    • Shimokawa, Mototsugu;
    • Otsuka, Taiga;
    • Hayashi, Kohei;
    • Sonoda, Yuki;
    • Honda, Takuya;
    • Nakao, Kazuhiko;
    • Shibuki, Taro;
    • Nakazawa, Junichi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Miwa, Keisuke;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Kubotsu, Yoshihito;
    • Makiyama, Akitaka;
    • Shimokawa, Hozumi;
    • Takeshita, Shigeyuki;
    • Nishikawa, Kazuo
    Publication type:
    Article
    4

    Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.

    Published in:
    Diseases of the Esophagus, 2025, v. 38, n. 3, p. 1, doi. 10.1093/dote/doaf029
    By:
    • Sugase, Takahito;
    • Kanemura, Takashi;
    • Matsuura, Norihiro;
    • Sugimura, Keijiro;
    • Takeoka, Tomohira;
    • Ushimaru, Yuki;
    • Masuike, Yasunori;
    • Yanagimoto, Yoshitomo;
    • Mori, Ryota;
    • Kitakaze, Masatoshi;
    • Kubo, Masahiko;
    • Mukai, Yosuke;
    • Komatsu, Hisateru;
    • Sueda, Toshinori;
    • Kagawa, Yoshinori;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    5

    Probability of Tumor Lysis Syndrome in Electrochemotherapy of Large Solid Tumors: A Pilot Study.

    Published in:
    European Journal of Cancer Care, 2025, v. 2025, p. 1, doi. 10.1155/ecc/8152344
    By:
    • Larijani, Amiradel;
    • Yazdanparast, Seyyed Mojtaba;
    • Pouria, Farshid Rostami;
    • Manoochehri, Navid;
    • Bayat, Mahdis;
    • Mansouri, Sama;
    • Sharghi, Nasim;
    • Mansouri, Sepideh;
    • Nabavian, Omid;
    • Memari, Fereidoon;
    • Mahmoodzadeh, Habibollah;
    • Miri, Seyed Rouhollah;
    • Abdolahad, Mohammad;
    • Gomez, Ricardo Santiago
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    췌장암의 외과적 치료.

    Published in:
    Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2025, v. 68, n. 6, p. 377, doi. 10.5124/jkma.25.0074
    By:
    • Yang, Jae Do
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Forecasting optimal treatments in relapsed/refractory mature T‐ and NK‐cell lymphomas: A global PETAL Consortium study.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1664, doi. 10.1111/bjh.20063
    By:
    • Sorial, Mark N.;
    • Han, Jessy Xinyi;
    • Koh, Min Jung;
    • Boussi, Leora;
    • Li, Sijia;
    • Duan, Rui;
    • Lu, Junwei;
    • Lei, Matthew M.;
    • MacVicar, Caroline T.;
    • Freydman, Jessica;
    • Malespini, Jack;
    • Aniagboso, Kenechukwu N.;
    • McCabe, Sean M.;
    • Peng, Luke;
    • Singh, Shambhavi;
    • Iwasaki, Makoto;
    • Eche‐Ugwu, Ijeoma Julie;
    • Gabler, Judith;
    • Fernandez Turizo, Maria J.;
    • Garg, Aditya
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study).

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35945
    By:
    • Ramaswamy, Anant;
    • Bhargava, Prabhat;
    • Gota, Vikram;
    • Srinivas, Sujay;
    • Sultana, Noorzia;
    • Mandavkar, Sarika;
    • Jadhav, Poonam;
    • Gandhi, Khushboo;
    • Mer, Neha;
    • Khan, Nafisa;
    • Vora, Manan;
    • Gujarathi, Himanshu;
    • Bhandare, Manish;
    • Chaudhari, Vikram;
    • Shrikhande, Shailesh V.;
    • Ostwal, Vikas
    Publication type:
    Article
    40

    Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35874
    By:
    • Godfrey, Elizabeth L.;
    • Mahoney, Forest;
    • Bansal, Varun V.;
    • Su, David G.;
    • Hanna, David N.;
    • Lopez‐Ramirez, Felipe;
    • Baron, Ekaterina;
    • Turaga, Kiran K.;
    • Benson, Al B.;
    • Setia, Namrata;
    • Winer, Joshua H.;
    • Gunderson, Craig G.;
    • Shah, Rupen;
    • Magge, Deepa R.;
    • Solsky, Ian;
    • Eng, Cathy;
    • Eng, Oliver S.;
    • Shergill, Ardaman;
    • Shen, John Paul;
    • Misdraji, Joseph
    Publication type:
    Article
    41

    Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35867
    By:
    • Godfrey, Elizabeth L.;
    • Mahoney, Forest;
    • Bansal, Varun V.;
    • Su, David G.;
    • Hanna, David N.;
    • Lopez‐Ramirez, Felipe;
    • Baron, Ekaterina;
    • Turaga, Kiran K.;
    • Benson, Al B.;
    • Cusack, James;
    • Winer, Joshua H.;
    • Gunderson, Craig G.;
    • Misdraji, Joseph;
    • Shah, Rupen;
    • Magge, Deepa R.;
    • Solsky, Ian;
    • Eng, Cathy;
    • Eng, Oliver S.;
    • Shergill, Ardaman;
    • Shen, John Paul
    Publication type:
    Article
    42
    43
    44

    Adenosine A<sub>3</sub> receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study.

    Published in:
    FEBS Open Bio, 2025, v. 15, n. 7, p. 1159, doi. 10.1002/2211-5463.70024
    By:
    • Morelli, Maria Beatrice;
    • Spinaci, Andrea;
    • Chang, Cui;
    • Volpini, Rosaria;
    • Lambertucci, Catia;
    • Landriscina, Matteo;
    • Conteduca, Vincenza;
    • Amantini, Consuelo;
    • Aguzzi, Cristina;
    • Zeppa, Laura;
    • Giangrossi, Martina;
    • Soverchia, Laura;
    • Santoni, Matteo;
    • Nabissi, Massimo;
    • Santoni, Giorgio;
    • Polidori, Carlo
    Publication type:
    Article
    45
    46
    47
    48
    49
    50